Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine and Attention on Frequency Tuning in Auditory Cortex
NCT05018117Phase 1Completed
- Sponsor
- University of California, Berkeley
- Start
- Jun 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of nicotine in age-related hearing loss (4 arms), sponsored by University of California, Berkeley. Primary endpoint: Frequency tuning of excitatory auditory fMRI cortical responses. Started Jun 2022; status: completed.
02
Drugs
nicotine
03
Conditions
age-related hearing loss
Beyond the preview
Go deeper on NCT05018117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018117.